Results 51 to 60 of about 3,735,339 (297)
Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii
Patients with severe carbapenem-resistant Acinetobacter baumannii (CRAB) infections currently face significant treatment challenges. When patients display signs of infection and the clinical suspicion of CRAB infections is high, appropriate treatment ...
Siqin Zhang +4 more
semanticscholar +1 more source
Acinetobacter Infections and Outcomes at an Academic Medical Center: A Disease of Long-Term Care
Background. Our study aims to describe the epidemiology, microbial resistance patterns, and clinical outcomes of Acinetobacter infections at an academic university hospital.
J. Townsend +6 more
semanticscholar +1 more source
Advances in BODIPY Derivatives for Antibacterial Phototherapy
This review systematically summarizes the design strategies and structure‐activity relationships of BODIPY‐based antibacterial phototherapy, covering molecular engineering of small‐molecule photosensitizers and nanoplatforms, bacterial targeting and carrier design, and discussing the challenges and future perspectives associated with clinical ...
Li Lv +9 more
wiley +2 more sources
Multidrug Resistant Acinetobacter in Patient with Ventilator Associated Pneumonia: Review Article [PDF]
Acinetobacter is a complex genus, with multiple species. Acinetobacter species are the common etiology of nosocomial infections, principally nosocomial pneumonia catheter-associated bacteremia and urinary tract infections.
Harsha V. Patil +2 more
doaj
Clinical and antimicrobial profile of Acinetobacter spp.: An emerging nosocomial superbug
Background: Recently, Acinetobacter has emerged as significant hospital pathogen, notoriously known to acquire antibiotic resistance to most of the commonly prescribed antimicrobials.
Purti C Tripathi +2 more
doaj +1 more source
Pyogenic Liver Abscess Caused by Acinetobacter lwoffii: A Case Report [PDF]
Acinetobacter lwoffii is a gram negative aerobic non-fermenter bacilli. It is considered as an important emerging pathogen after Acinetobacter baumannii in patients with impaired immune system and in nosocomial infections.
N. Pal Singh +3 more
doaj +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source
BACKGROUND Pandrug-resistant Acinetobacter baumannii (PDRAB) is increasingly being reported as a nosocomial pathogen worldwide but determining its clinical impact is challenging.
Stamatis Karakonstantis +3 more
semanticscholar +1 more source
This study presents a new biodegradable coating for titanium implants using a natural antimicrobial peptide, caerin 1.9. Applied via solvent casting, the coating offers sustained antibacterial protection and promotes healing. Tested on 3D‐printed porous titanium scaffolds, it effectively prevented infection—including against resistant bacteria—while ...
Hejie Li +7 more
wiley +1 more source
Acinetobacter Species: Phenotypic Characterization And Antimicrobial Resistance
Background: Acinetobacter species is ubiquitous, aerobic gram-negative coccobacilli that are now emerging as an important nosocomial pathogen. Objectives: The present study was designed to know the prevalence of Acinetobacter in various clinical ...
Medhabi Shrestha, Basuda Khanal
doaj +1 more source

